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Objectives
• Definition of CAA as a disease
• Key clinical/MRI signatures
• Implications for treatments, BP, OAC etc.
• latest developments, current trends – No RCTs to    
date.
Key Take Home Message
•MRI is crucial when CAA is suspected
– For diagnosis
– For prognosis
• Cortical superficial siderosis – driver of
bleeding
• CAA is not only about hemorrhage –
ischemic Lesions, encephalopathies, 
inflammation/angiitis.
What is CAA
Operational definitions – 3 intersecting levels:
1. Neuropathological level
2. Key clinical presentations / Boston criteria
❑ Spontaneous lobar ICH (10-30% of all ICH)
❑ CAA non-ICH syndromes
“Amyloid spells”, acute cSAH
dementia
CAA related vaculopathies
3. MRI markers and other biomarkers
❑ Early diagnosis – incidental finding
Cerebral Amyloid Angiopathy
• Disease of the elderly 
(~50% of ICH in >80)
• Deposition of amyloid 
protein in 
media/adventitia of small 
cortical arteries, 
arterioles and capillaries
• Cortex and cerebellum
What is CAA?
Pathologically common, clinically relevant
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CAA pathophysiology: complex, 
poorly understood
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Brain, Volume 140, Issue 7, July 2017, Pages 1829–1850, https://doi.org/10.1093/brain/awx047
The content of this slide may be subject to copyright: please see the slide notes for details.
Figure 5 Suggested heuristic schematic of the possible different 
phenotypes of CAA and directions in the expression of ...
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Heriditary CAA Spectrum
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CAA diagnosis – Boston Criteria
16
17
18
A schematic representation of the spectrum of haemorrhagic and ischaemic manifestations of 
sporadic cerebral amyloid angiopathy, visible on MRI.
Andreas Charidimou et al. J Neurol Neurosurg Psychiatry 
2012;83:124-137
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Why is CAA clinically relevant?
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Why CAA as disease target
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Our Team
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Neurointensivists
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Neuro ICU (C-6West)
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